Insider Trading Summary for BioSante Pharmaceuticals, Inc. (ANIP): Year

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
16-Aug-23 8:00 PM View:	16-Aug-23 Private Sale ($11.70M)	Meridian Venture Partners I... 10% Owner		BioSante Pharmaceuticals, Inc. - ANIP	(10%) 2.02M to 1.82M	0	0	--	--	Show Txns Hide Txns

11-Apr-24 9:13 PM View:	10-Apr-24 Payment of Exercise ($187.42K)	Marken James G. SVP Ops & Prod Dev		BioSante Pharmaceuticals, Inc. - ANIP	(12%) 131.63K to 116.01K	0	0	--	--	Show Txns Hide Txns

24-May-23 4:31 PM View:	23-May-23 Grant 0	Nash David Director		BioSante Pharmaceuticals, Inc. - ANIP	22% 31.7K to 38.56K	0	0	--	--	Show Txns Hide Txns

24-May-23 10:00 PM View:	23-May-23 Grant 0	Haughey Thomas Director		BioSante Pharmaceuticals, Inc. - ANIP	17% 40.25K to 47.12K	0	0	--	--	Show Txns Hide Txns

24-May-23 4:33 PM View:	23-May-23 Grant 0	Thoma Jeanne Director		BioSante Pharmaceuticals, Inc. - ANIP	23% 29.33K to 36.2K	0	0	--	--	Show Txns Hide Txns

06-Mar-24 4:20 PM View:	04-Mar-24 Private Sale ($456.40K)	Pera Antonio R Director		BioSante Pharmaceuticals, Inc. - ANIP	(11%) 29.76K to 26.63K	0	0	--	--	Show Txns Hide Txns

25-Mar-24 4:09 PM View:	23-Mar-24 Payment of Exercise ($1.21M)	Lalwani Nikhil PRESIDENT & CEO Director		BioSante Pharmaceuticals, Inc. - ANIP	(4%) 410.06K to 394.17K	0	0	--	--	Show Txns Hide Txns

24-May-23 4:34 PM View:	23-May-23 Grant 0	Walsh Patrick D Director		BioSante Pharmaceuticals, Inc. - ANIP	11% 63.44K to 70.3K	0	0	--	--	Show Txns Hide Txns

07-Mar-24 9:21 PM View:	07-Mar-24 Payment of Exercise ($166.38K)	Gutwerg Ori SVP, GENERICS		BioSante Pharmaceuticals, Inc. - ANIP	27% 62.97K to 80.21K	0	0	--	--	Show Txns Hide Txns

Yesterday 5:48 PM View:	01-May-24 Private Sale (Planned) ($1.33M)	Gassert Chad SVP - CORP. DEV. & STRATEGY		BioSante Pharmaceuticals, Inc. - ANIP	(33%) 422.17K to 282.9K	0	0	--	--	Show Txns Hide Txns

22-Apr-24 6:26 PM View:	19-Apr-24 Sale (Planned) ($1.10M)	Shanmugam Muthusamy HEAD OF R&D, COO-NOVITIUM OPS Director		BioSante Pharmaceuticals, Inc. - ANIP	(38%) 1.39M to 856.27K	0	0	--	--	Show Txns Hide Txns

07-Mar-24 9:16 PM View:	07-Mar-24 Payment of Exercise ($140.76K)	Mutz Christopher HEAD OF RARE DISEASE		BioSante Pharmaceuticals, Inc. - ANIP	28% 66.61K to 85.28K	0	0	--	--	Show Txns Hide Txns

24-May-23 4:36 PM View:	23-May-23 Grant 0	Tannenbaum Renee P Director		BioSante Pharmaceuticals, Inc. - ANIP	51% 13.35K to 20.21K	0	0	--	--	Show Txns Hide Txns

15-Apr-24 6:28 PM View:	12-Apr-24 Private Sale (Planned) ($16.95K)	Cook Meredith SR. VP, GENERAL COUNSEL & SEC.		BioSante Pharmaceuticals, Inc. - ANIP	51% 39.54K to 59.73K	0	0	--	--	Show Txns Hide Txns

01-Mar-24 4:59 PM View:	29-Feb-24 Payment of Exercise ($79.38K)	Davis Krista SVP, CHIEF HR OFFICER		BioSante Pharmaceuticals, Inc. - ANIP	40% 36.7K to 51.55K	0	0	--	--	Show Txns Hide Txns

11-Apr-24 9:12 PM View:	10-Apr-24 Payment of Exercise ($303.60K)	Carey Stephen P. SVP & CFO		BioSante Pharmaceuticals, Inc. - ANIP	(4%) 173.48K to 166.97K	0	0	--	--	Show Txns Hide Txns

23-Aug-23 8:44 PM View:	21-Aug-23 Grant 0	Leonard Matthew J Director		BioSante Pharmaceuticals, Inc. - ANIP	100% 0 to 7.58K	0	0	--	--	Show Txns Hide Txns

BioSante Pharmaceuticals, Inc. (ANIP)

Last Year

05-May-23 -- 04-May-24

Company Sentiment

Biotechnology

Drugs

Two Year Chart

05-May-22 -- 04-May-24

Price ($)

Sentiment

Buy & Sell Volume ($)

Recent Insider Trades

Buy:	0	--
Sell:	0	--